Evaluation of Educational Interventions Targeting Beliefs About Human Papillomavirus (HPV)

HPV Clinical Trial

Official title:

Evaluation of Educational Interventions Targeting Beliefs About Human Papillomavirus (HPV) Among Female Employees

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

• NCT number: NCT06198491
• Other study ID #: E-80558721-050.99-413737
• Status: Enrolling by invitation
• Phase: N/A
• Start date: March 29, 2024
• Est. completion date: May 2024

Study information

• Verified date: April 2024
• Source: Eskisehir Osmangazi University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The goal of this clinical trial is to compare the effects of two different educational training programs on beliefs about Human Papillomavirus (HPV) in a group of female hospital employees. The main questions it aims to answer are: • Within the scope of the study, are the training programs provided to reduce misconceptions about HPV effective? • Which educational program is more effective in reducing misconceptions about HPV? Participants will • Complete a pre-test online the day before the first training date to determine the level of their misconceptions about HPV. • Receive informative messages via Whatsapp once a day for three days according to the training program they are assigned to. • Repeat the pre-test at the end of the training programs and one month later. • Receive the more effective training program after one month after the test repetition for the control group. Researchers will compare "Misbeliefs about HPV" and "Current Knowledge about HPV" titled training programs on reducing misconceptions about HPV.

Description:

The human papillomavirus (HPV) can cause health problems ranging from warts in the mouth or genital area to cervical, vaginal, vulvar, penile and anal cancers. Some beliefs about diseases or infectious agents have a negative impact on the early diagnosis and treatment of diseases, particularly by increasing the stigmatization effect of sexually transmitted diseases. Features such as the fact that mucosal contact is sufficient for transmission, that infected people can be symptom-free for a long time, that cancer often develops slowly, and that there are similarities with other sexually transmitted viruses such as HIV (human immunodeficiency virus) or herpes can have a negative impact on knowledge and beliefs about HPV.

It is known that it is crucial to emphasize correct information, not to repeat or point out inaccuracies when taking action to combat false beliefs or myths. In the context of the COVID-19 pandemic, the importance of this approach has been frequently emphasized in the guidance contained in the confirmatory information on misinformation and disinformation. In our study, we want to compare the effectiveness of education models in which false beliefs or myths about HPV are conveyed before or after the current information.

Recruitment information / eligibility

• Status: Enrolling by invitation
• Enrollment: 102
• Est. completion date: May 2024
• Est. primary completion date: May 2024
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Woman

• Age >18 years and older

• Those who agree to participate in the study

Exclusion Criteria:

• Age <18 years

• Those who not agree to participate in the study

Related Conditions & MeSH terms

• Beliefs
• Education, Medical
• HPV
• Intervention

Intervention

Behavioral:
• Misbeliefs about HPV training
Intervention trainings mentioned false beliefs before or after the current knowledge

Locations

Country	Name	City	State
Turkey	Eskisehir Osmangazi University Public Health Department	Odunpazari	Eskisehir

Sponsors (1)

Lead Sponsor	Collaborator
Eskisehir Osmangazi University

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Health Beliefs about Human Papillomavirus (HPV)	Measuring with: "False Beliefs About HPV Scale"	From enrollment to the end of intervention at 4 weeks